As of March 2022, this study is now open to all people with NSCLC who were diagnosed under age 50.

This study is for patients who were diagnosed before age 50 with non-small cell lung cancer (NSCLC) and have completed comprehensive biomarker testing. Only individuals in the United States are eligible.

The Epidemiology of Young Lung Cancer (EoYLC) study seeks to identify common risk factors among younger lung cancer patients to help researchers crack the code on a young lung cancer diagnosis.

Eligible patients will be asked to fill out a confidential, online survey capturing information about demographics, medical history, active and passive smoking history, early life exposures, and more. Participants will also be asked to provide a small sample of blood, which can conveniently be collected at their home or through their provider.

The survey is open to patients across the U.S. Learn more and sign up to participate online or call 888-443-6952.

Click here to view/download the EoYLC study flyer.

Sign up today
GO2 and ALCMI combined logo

This study is a collaboration between the Addario Lung Cancer Medical Institute and GO2 for Lung Cancer.